Response to Letter to Editor Entitled: Improvement of Nonalcoholic fatty liver disease in ALT at ≥12 months after Roux-en-Y Gastric Bypass (RYGB) and Sleeve Gastrectomy (SG), No effect in ALT and AST at < 12 months after SG and in AST at > 12, ≤24 months after RYGB by Wang et. al

We begin by complimenting Wang et al. for their research into treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) after Roux-en-Y Gastric Bypass (RYGB) and Laparoscopic Sleeve Gastrectomy (LSG) through the analysis of Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) values at different timepoints. This is a burgeoning field of research, as NAFLD rates continue to rise globally. Bariatric surgery has been proven in numerous studies to improve AST and ALT values after bariatric surgery (1).
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Tags: Letter to the Editor Source Type: research